Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C
K. Patel*, R. Jhaveri, J. George, G. Qiang, C. Kenedi, K. Brown, C. Cates, A. Zekry, H. L. Tillmann, L. Elliott, R. Kilaru, J. Albrecht, A. Conrad, J. G McHutchison
Dive into the research topics of 'Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C'. Together they form a unique fingerprint.